Failure of HPV E6 to rapidly degrade p53 in human HeLa x PNET cell hybrids

Oncogene

Volumn 14, Issue 14, 1997, Pages 1669-1678

  Isaacs, Jennifer S ^a   Chen, Pengchin ^a,d   Garza, Armandina ^b   Hansen, Marc F ^b,e   Barrett, J Carl ^c   Weissman, Bernard E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

E6; p53; Tumor suppressor genes

Indexed keywords

PROTEIN P53; UBIQUITIN; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; HYBRID CELL; NEUROEPITHELIOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; WART VIRUS;

HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0030992492     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201001     Document Type: Article

References (67)

1. Anker L, Ohgaki H, Ludeke BI, Herrmann H-D, Kleihues P and Westphal M. (1993). Int. J. Cancer, 55, 982-987.
2. Bernard BA. (1993). Molecular biology of the skin: The keratinocyte. Darmon MABM. (ed). Academic Press, Inc: San Diego, pp. 207-243.
3. Blumenfeld N, Gonen H, Mayer A, Smith CE, Siegel NR, Schwartz AL and Ciechanover A. (1994). J. Biol. Chem., 269, 9574-9581.
4. Butz K, Shahabeddin L, Geisen C, Spitousky D, Ullman A and Hoppe-Seycer F. (1995). Oncogene, 10, 927-936.
5. Chen P, Ellmore N and Weissman BE. (1994). Mol. Cell. Biol., 14, 534-542.
6. Chen T-M and Defendi V. (1992). Oncogene, 7, 1541-1547.
7. Chowdary DR, Dermody J, Jha KK and Ozer HL. (1994). Mol. Cell. Biol., 14, 1997-2003.
8. Ciechanover A, DiGiuseppe JA, Bercovich B, Orian A, Richter JD, Schwartz AL and Brodeur GM. (1991). Proc. Natl. Acad. Sci. USA, 88, 139-143.
9. Cripps KJ, Purdie CA, Carder PJ, White S, Komine K, Bird CC and Wyllie, AH. (1994). Oncogene, 9, 2739-2743.
10. Delmolino L, Band H and Band V. (1993). Carcinogenesis, 14, 827-832.
11. Donnehower L and Bradley A. (1993). Biochem. Biophys. Acta, 1155, 181-205.
12. El-Deiry WS, Tokino T, Velculescu VE, Levy D, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
13. Eytan D, Ganoth D, Armon T and Hershko A. (1989). Proc. Natl. Acad. Sci. USA, 86, 7751-7755.
14. Fouret P, Dabit D, Sibony M, Alili-D, Commo F, Saint Guily JL and Callard P. (1995). Am. J. Pathol., 146, 599-604.
15. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Dosik H and Parks WP. (1974). J. Natl. Cancer Inst., 51, 1417-1423.
16. Gudas JM, Oka M, Diella F, Trepel J and Cowan KH. (1994). Cell Growth Diff., 5, 295-304.
17. Hainaut P and Milner J. (1992). EMBO J., 11, 3513-3520.
18. Hainaut P and Milner J. (1993). Cancer Res., 53, 4469-4473.
19. Halbert CL, Demers GW and Galloway DA. (1991). J. Virol., 65, 473-478.
20. Halevy O, Hall A and Oren M. (1989). Mol. Cell. Biol., 9, 3385-3392.
21. Hall IJ, Gioeli D, Weissman BE and Tlsty TD. (1996). Genes Chrom. Cancer, in press.
22. Hall PA, McKee PH, Menage H du P, Dover R and Lane DP. (1993). Oncogene, 8, 203-207.
23. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ. (1993). Cell, 75, 805-816.
24. Hollenstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
25. Hubbert NL, Sedman SA and Schiller JT. (1992). J Virol., 66, 6237-6241.
26. Huibregtse JM, Scheffner M and Howley PM. (1991). EMBO J., 10, 4129-4135.
27. Huibregtse JM, Scheffner M and Howley PM. (1993a). Mol Cell. Biol., 13, 4918-4927.
28. Huibregtse JM, Scheffner M and Howley PM. (1993b). Mol. Cell. Biol., 13, 775-784.
29. Johnson M, Dimitrov D, Vojta PJ, Barrett JC, Noda A, Pereira-Smith OM and Smith JR. (1994). Mol. Carcinog., 11, 59-64.
30. Kastan MB, Onyekwere O, Estabrooks LL and Wilson SJ. (1991). Cancer Res., 51, 6304-6311.
31. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace-Jr AJ. (1992). Cell, 71, 587-597.
32. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB. (1992). Proc. Natl. Acad. Sci. USA, 89, 7491-7495.
33. Landesman Y, Bringold F and Kimchi A. (1994). Oncogene, 9, 1241-1245.
34. Lechner MS, Mack DH, Finicle AB, Crook T, Vousden KH and Laimins LA. (1992). EMBO J., 11, 3045-3052.
35. Lee, KA, Finnegan MCM, Sheridan E, Hancock BW, Goepel JR, Royds J and Goyns MH. (1994). Ann. Oncol., 5, 85-88.
36. Li Y, Jenkins CW, Nichols MA and Xiong Y. (1994). Oncogene, 9, 2261-2268.
37. Liang XH, Volkmann M, Klein R, Herman B and Lockett S. (1993). Oncogene, 8, 2645-2652.
38. Lowry DR, Kirnbauer R and Schiller JT. (1994). Proc. Natl. Acad. Sci. USA, 91, 2436-2440.
39. Maheswaran S, Englert C, Bennett P, Heinrich G and Haber DA. (1995). Genes & Dev., 9, 2143-2156.
40. Marston NJ, Crook T and Vousden KH. (1994). Oncogene, 9, 2707-2716.
41. Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T and Hayashi K. (1991). Oncogene, 6, 1313-1318.
42. Masuda H, Miller C, Koeffler HP, Battifora H and Cline MJ. (1987). Proc. Natl. Acad. Sci. USA, 84, 7716-7719.
43. Maxwell SA and Roth JA. (1994). Crit. Rev. Oncog., 5, 23-57.
44. Medcalf EA and Milner J. (1993). Oncogene, 8, 2847-2851.
45. Meek DW. (1994). Sem. in Cancer Biol., 5, 203-210.
46. Milner J. (1994). Sem. in Cancer Biol., 5, 211-219.
47. Momand J, Zambetti GP, Olson D, George DL and Levine AJ. (1992). Cell, 69, 1237-1245.
48. Oren M. (1992). FASEB J., 6, 3169-3176.
49. Oren M, Maltman W and Levine AJ. (1981). Mol. Cell. Biol., 1, 101-110.
50. Scheffner M, Huibregtse JM, Vierstra RD and Howley PM. (1993). Cell, 75, 495-505.
51. Scheffner M, Munger K., Byrne JC and Howley PM. (1991). Proc. Natl. Acad. Sci. USA, 88, 5523-5527.
52. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM. (1990). Cell, 63, 1129-1136.
53. Sedman SA, Hubbert NL, Vass W, Lowry DR and Schiller JT. (1992). J. Virol., 66, 4201-4208.
54. Selkirk JK, Merrick BA, Stackhouse L and He C. (1994). Applied and Theor. Electro., 4, 11-18.
55. Spandau DF. (1994). Oncogene, 9, 1861-1868.
56. Tervahauta AI, Syrjansen SM, Mantyjarvi R and Syrjanen KJ. (1994). Cytopathology, 5, 282-293.
57. Thomas M, Massimi P, Jenkins J and Banks L. (1995). Oncogene, 10, 261-268.
58. Tominaga O, Hamelin R, Trouvat V, Salmon RJ, Lesec G, Thomas G and Remvikos Y. (1993). Oncogene, 8, 2653-2658.
59. Treier M, Staszewski LM and Bohmann D. (1994). Cell, 78, 787-798.
60. Villuendas R, Piris MA, Algara P, Sanchez-Beato M, Sanchez-Verde L, Martinez JC, Orradre JL, Garcia P, Lopez C and Martinez P. (1993). Blood, 82, 3151-3156.
61. Vogelstein B and Kinzler KW. (1992). Cell, 70, 523-526.
62. Weissman BE. (1990). Cancer Surv., 9, 475-485.
63. Weissman BE and Stanbridge EJ. (1980). Cytogenet. Cell Genet., 28, 227-239.
64. Weissman BE and Stanbridge EJ. (1983). J. Natl. Cancer Inst., 70, 667-672.
65. Werness BA, Levine AJ and Howley PM. (1990). Science, 248, 76-79.
66. White A, Livanos EM and Tlsty TD. (1994). Genes and Dev., 8, 666-677.
67. Xiong Y, Hannon H, Zhang H, Casso D, Kobayashi R and Beach D. (1993). Nature, 366, 701-704.